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A case of Rhinoceros viper (Bitis nasicornis)
bite is reported. The bitten hand distended to the
wrist, which was tense and painful, with only mild
local livid discolouration manifested around the
fang mark. Slight hypertension with moderate
tachycardia and temporary coagulopathy were ob-
served. The patient received analgesic and intra-
venous fluids, antibiotics and anti-tetanus therapy.
Use of antiserum was not necessary. The bitten
person was treated in the main centre for snake-
bite first aid: in the Toxicological Ward of Erzsé-
bet Hospital of Budapest. We attach importance
to the implications of this case because envenom-
ing by B. nasicornis being relatively rare in captiv-
ity all over the world (particularly in Europe and
the USA), as well as in the wilderness in Africa.
Key words: snake; first aid; venom; coagulopathy;
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Abstract
Snake-bite accidents caused by different ven-
omous species deserve much more attention
worldwide [1], especially since there is limited ex-
perience and a paucity of information available
for bites (and their consequences) from certain
species, e.g., B. gabonica or this case of B. nasicornis.
These are medically important species, mainly
due to their highly toxic venom and large venom
yield. The Rhinoceros viper (Bitis nasicornis) is
one of the largest vipers in Africa with its total
length 100–10 cm, however the adult size of this
species differs across its range [2]. Its distribution
spreads from West Africa through Central Africa
to western Kenya, thus its geographical range
partly overlaps with that of the closely related
B. gabonica [2, 3].
In Africa, the Puff adder (Bitis arietans) is re-
sponsible for the majority of bites from the Bitis
genera [3] due to its large distribution and diverse
habitats, while the other two puff adder species
mentioned above have hardly ever inflicted acci-
dents in their original habitats [3, 4]. Unfortu-
nately, there is a lack of experience in B. nasicornis
envenomations and the symptoms caused, as acci-
dents are rare in its natural environment due to its
sedentary and nocturnal lifestyle [2, 3]. Data of
B. nasicornis bites in their natural habitats among
the local human population are often unreliable,
as positive identification of the snake seldom oc-
curs. Envenomings are not frequent in captivity
either, probably due to the snake’s calm behaviour
[]. Only four bites of B. nasicornis have been
recorded, all in the USA [6–]: one in Minnesota
in 196 [6], later another victim suffered two bites
in St. Louis,Missouri in April then in May in 2002
[7], and one fatal accident occurred in Dayton,
Ohio in 2003 [7, ].
Nowadays the keeping of tropical venomous
snakes is in fashion in Hungary [9].The species of
the genus Bitis are beloved and all three big-bodied
Bitis species (B. arietans, B. gabonica, B. nasicornis)
are present in private collections. Bitis arietans has
already been involved in several severe or even
life-threatening accidents in the last decades in
Hungary [9, 10]. On account of the similar effects
of the toxin of B. nasicornis compared to the venom
of B. gabonica, toxicologists rely on experiences
gathered during accidents caused by this species
when regarding the consequences of B. nasicornis
intoxication [11]. For this reason we attach partic-
ular importance to reporting the circumstances of
a single B. nasicornis accident and its clinical out-
comes, discovered during a nationwide survey of
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There are differences of opinion regarding
routine antibiotic use in cases of snake-bite. On
the one hand the risk of routine antibiotic therapy
leading to increases in resistant bacterial phyla
[13] is well known, on the other, antibiotic use is
not essential in many snake-bite incidents [14,
1]. Many authors [16–1] assume that routine
antibiotic therapy is necessary due to the bacterial
flora of snakes’ saliva, especially in cases of acci-
dents caused by a species with haemo-cytotoxic
venom such as the family of Viperidae [1].
Justifying the use and explaining the benefit
of anti-tetanus therapy is problematic, in particu-
lar since tetanus after snake-bite has not been
documented [19]. Necrosis, blistering and abscess
formation are often observed following Bitis bites
[4, , 20, 21] but are caused in part by actions of
the haemo- and cytotoxicity of the venom [1].
Local necrosis evolves on account of the proper-
ties of the venom (i.e., haemo- cyto- and myotox-
icity) [1, 1], possibly interacting with the bacte-
rial flora of snake’s saliva, and the natural flora of
human skin [1].
A similar case was recorded in 2002, when
severe necrosis necessitated amputation of the pa-
tient’s finger following snake-bite [7]. In our case
A 30-year-old healthy male was transported
by car to the Toxicological Ward of Erzsébet
Hospital of Budapest, the main centre for snake-
bite first aid, on 9th November 2001. The person
was bitten by an adult (90–100 cm long) male Rhi-
noceros viper (B. nasicornis) (fig. 1). He had never
been bitten previously (patient’s personal com-
ment). The snake’s last feeding date was unknown.
The captive bred specimen’s ancestral origin was
Ghana,West Africa. The specimen was estimated
to be 2–3 years old and its owner bought it, when
it was still juvenile (patient’s personal comment).
According to the patient, the snake had always
been calm and handled easily and special caution
was only necessary during the snake’s feeding
time. The accident happened when the owner
pulled the viper from its cage with a snake-hook.
After being bitten the victim was transported
to hospital within an hour and did not receive any
first aid until admission. The bite occurred with
one fang only and was clearly visible on the pulp
of the patient’s right index-finger (fig. 2). At ad-
mission he had clear consciousness, was wide-
awake and in a good mood considering the cir-
cumstances. Local symptoms were moderate: the
bitten hand was oedematous (oedema extended to
the wrist), the fingers were moderately swollen
and tense, and slight livid discolouration devel-
oped around the fang mark (fig. 2). No other local
symptoms occurred. He experienced slight hyper-
tension, with systolic pressure of 1 mmHg, and
diastolic of 0 mmHg. The ECG did not show
any abnormal changes despite the fact that the
venom of B. nasicornis can affect heart function
[11, 12]. Only moderate tachycardia (10/min)
was observed at the time of admission. Of the lab-
oratory findings some rates, especially those of the
cardiovascular system, diverged from the normal
ones (table 1). The envenomed person had mild
temporary coagulopathy (table 1), represented
by the following laboratory results: INR 1.30;
PTT 32 sec; and IVY 1.1 min.
Infusion (lactated Ringer solution 00 ml)
and strong antiphlogistic (Tramadolium chloratum
0 mg i.v.) were administered at admission. Infu-
sion is administrated routinely following mild to
moderate snake-bite envenomation in Hungary
[9]. Furthermore the patient received tetanus an-
titoxin injection (1 ampoule −  ml) and antibiotic
therapy (Clindamicin 2x300 mg). The analgesic
was necessary due to the tension and intense pain
of the hand. Antivenom therapy was not consid-
ered. Hospital observation lasted for 4 days only.
The patient complained of pain – presumably due
to arthralgia of the bitten hand – for two weeks
after the incident.
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anti-tetanus prophylaxis and antibiotic (clind-
amicin 2x300 mg/d) administration were deemed
necessary to prevent secondary infections. Anti-
biotics and tetanus antitoxin are often applied for
snake-bite therapy in Hungary [9]. The venom of
B. nasicornis is haemo-cytotoxic, potently destruc-
tive to cellular elements of blood, degrading tis-
sues and causing coagulation disorders [3, 12, 22,
23]. It also contains myocardiotoxins [11] affect-
ing cardiac function and blood pressure, thus it
can readily provoke arrhythmia, cardiac-mediated
hypotension and myocardial damage.
Local and systemic bleeding can occur owing
to the haemotoxic components of the venom.
The venom yield of an adult specimen is high
(200 mg – dry weight) [2], similar to the same-
sized B. arietans (10–20 mg – dry weight) [24].
With its long fangs (20–300 mm) the species
usually injects the venom directly into the mus-
cles. The lethal dose of venom is only .6 mg/kg
i.m., thus B. nasicornis produces the most toxic
venom intramuscularly of the big-bodied Bitis
species (i.e., B. gabonica and B. arietans) [20]. An
envenoming is potentially as dangerous as one
arising from one of the two taxa mentioned above
and can be fatal [7]. In Europe, two polyvalent
antivenins (Ipser Africa® Pasteur Vaccins, France;
and Anti-Bitis-Echis-Naja Africa®, Institut Pas-
teur, France) were produced against the bite of
B. nasicornis, while another polyvalent serum
(Saimr Polyvalent Snake Antivenom®, South
African Vaccine Producers, Johannesburg, South
Africa) is made in Africa. The gender of the snake
is important as sexual venom variation is present
in this species [12]. The female’s venom contains
one component absent from the venom of males
[12], which might influence the outcome of a poi-
soning. Geographical venom variation might also
influence the development of symptoms, a fact
already proved in many other species [2]. The
body size and age of the species affect the
ophidism as well. Juveniles of variant species of
Viperidae have more toxic venom, which has
higher coagulant activity and lower proteolytic
effects [2]. Experience shows that B. nasicornis
bites cause intense pain and moderate to severe
oedema of the bitten extremity. Compartment
syndrome may also develop in severe cases, as has
been observed among victims of B. arietans and/or
B. gabonica. In our case, the local effects were sim-
ilar to one of the US cases, where also the finger
was bitten. Following this latter event the hand
and the wrist became oedematous and intensive
pain developed after injury [7]. Local necrosis also
occurred [7], although this is often less serious
and extensive than in the case of B. arietans bites.
In this case the patient was lucky not to apply
a tourniquet as first aid; since the application
of pressure dressings contributes to necrosis at
the various Bitis bites [17]. Besides the typical
local symptoms of puffadder-like bites, systemic
symptoms also developed in our patient involving
moderate tachycardia, slight hypertension and
temporary coagulopathy. Temporary coagulo-
pathy included shortened prothrombin time
(table 1), and disappeared spontaneously without
any medical intervention. It is likely that different
coagulopathies will develop in moderate and
severe poisonings by B. nasicornis owing to the
haemostatic activity of their venom [23]; however
these may also appear in mild cases. Fortunately,
B. nasicornis are seldom encountered in Hun-
garian private collections, probably owing to diffi-
culties in their procurement. The accident in
question may have been contributed to by human
negligence, as occurs in almost every snake-bite
incident, mainly with specimens in captivity [1].
Most probably this was “only” a warning bite,
which occurred with one fang only and the snake
injected a small amount of venom. Thus our pa-
tient had very lucky.
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Laboratory analysis Patient’s rates Patient’s rates Normal rates
09. 11. 2001 10. 11. 2001 [26, 27]
(Unit) (Unit) (Unit)
Blood
WBC 9.2 (M/μL) 12. (M/μL) 4.–11.0 (M/μL)*
Lymphocytes 22.9 (%) 12.6 (%) 17–4 (%)
Granulocytes 73.4 (%) 3.0 (%) 42–74 (%)
Lymphocytes abs. 2.1 (G/l) 1.6 (G/l) 1.–4.0 (G/l)
Granulocytes abs. 6. (G/l) 10.4 (G/l) 2.0–7. (G/l)
RBC .3 (M/μL) 4.90 (M/μL) 4.–. (M/μL)*
Haemoglobin (Hb) 163 (g/l) 10 (g/l) 130–10 (g/l)*
Haematocrit 0.1 (l/l) 0.47 (l/l) 40–0 (%)*
Mean Cell Volume 9 (fl) 97 (fl) 0–100 (fl)
(MCV)
Mean Cell Haemoglobin 30.3 (pg) 30.6 (pg) 27–32 (pg)
(MCH)
Mean Cell Haemoglobin 31.9 (g/l) 31.6 (g/l) 300–30 (g/l)
Concentration (MCHC)
Thrombocyte count 271 (G/l) 20 (G/l) 10–400 (G/l)
Thrombin time 20 (sec) 19 (sec) 16–21 (sec)
Fibrinogen 2.0 (g/l) 1. (g/l) 1.–4.0 (g/l)
Activated Partial 32 (sec) 33 (sec) <29 (sec)
Thromboplastin Time (PTT)
International Normalised 1.30 1.70 –
Ratio (INR)
Coagulation time 4.10 (min.) 4.2 (min) <9 (min)
SGOT 43 (U/l) – <0 (U/L)*
Alkaline phosphatase 143 (U/l) – 2–100 (U/l)
Carbamid .0 (mmol/l) – 3.0–.0 mmol/l
IVY 1.1 (min.) – –
Urine
RBC 3–4 (C/visual area) – >2*
WBC –6 (C/visual area) – >2*
Table 1
laboratory findings (*normal rates in males).
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